Parallel recovery of MK-801-induced spatial learning impairment and neuronal injury in male mice

被引:18
作者
Brosnan-Watters, G [1 ]
Wozniak, DF [1 ]
Nardi, A [1 ]
Olney, JW [1 ]
机构
[1] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
关键词
MK-801; dizocilpine; spatial learning and memory; mice; sensorimotor; neuronal injury; NMDA receptor antagonist;
D O I
10.1016/S0091-3057(98)00149-X
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The relationship between spatial learning impairment and reversible neuronal injury in the posterior cingulate/retrosplenial (PC/RS) cortex induced by MK-801 in male mice was studied using a four-corner holeboard task. Mice were dosed with 1 mg/kg MK-801 and tested on acquisition of a new "baited" hole at 5 or 12 h posttreatment. Acquisition in drugged mice was impaired at 5 h, but not at 12 h posttreatment. Their retention performances were unaffected 24 h after either the 5 or 12 h posttreatment acquisition sessions. MK-801 (1 mg/kg) was found to induce locomotor hyperactivity and some sensorimotor impairment at 5 h posttreatment, which could have contributed to the acquisition deficit. However, nonassociative effects of the drug were not prominent because this same dose did not impair holeboard performance at 5 h posttreatment when the task was well learned. Histologic experiments showed that many injured neurons (containing cytoplasmic vacuoles) were present in the PC/RS cortex at 5 h posttreatment but the reaction was essentially reversed at 12 h posttreatment. The results suggest that the acquisition impairment and neuronal injury induced by MK-801 evolve and recover in parallel according to a similar time schedule. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:111 / 122
页数:12
相关论文
共 50 条
[21]   Haloperidol and Clozapine Reverse MK-801-Induced Deficits in Hypoactivity, but Not the Impairment of Spatial Memory in Sprague-Dawley Rats [J].
Liu, Huanzhong ;
Ren, Zhenhua ;
Zhong, Jian ;
Cai, Han ;
Chen, Xuequan ;
Li, Jun .
INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2014, 10 (02) :120-128
[22]   The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice [J].
Zofia Rogóż ;
Katarzyna Kamińska .
Pharmacological Reports, 2016, 68 :116-120
[23]   Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice [J].
Zofia Rogóż .
Pharmacological Reports, 2013, 65 :1401-1406
[24]   Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice [J].
Rogoz, Zofia .
PHARMACOLOGICAL REPORTS, 2013, 65 (05) :1401-1406
[25]   The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice [J].
Rogoz, Zofia ;
Kaminska, Katarzyna .
PHARMACOLOGICAL REPORTS, 2016, 68 (01) :116-120
[26]   Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice [J].
Park, Se Jin ;
Lee, Younghwa ;
Oh, Hee Kyong ;
Lee, Hyung Eun ;
Lee, Younghwan ;
Ko, Sang Yoon ;
Kim, Boseong ;
Cheong, Jae Hoon ;
Shin, Chan Young ;
Ryu, Jong Hoon .
NEUROPHARMACOLOGY, 2014, 86 :49-56
[27]   Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice [J].
Zhou, Xingqin ;
Chen, Quancheng ;
Hu, Xindai ;
Mao, Shishi ;
Kong, Yanyan .
BEHAVIOURAL BRAIN RESEARCH, 2014, 258 :153-159
[28]   Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice [J].
Rogoz, Zofia ;
Wasik, Agnieszka ;
Lorenc-Koci, Elzbieta .
PHARMACOLOGICAL REPORTS, 2018, 70 (04) :623-630
[29]   Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice [J].
Zofia Rogóż ;
Agnieszka Wąsik ;
Elzbieta Lorenc-Koci .
Pharmacological Reports, 2018, 70 :623-630
[30]   Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice [J].
de Oliveira, RV ;
Dall'Igna, OP ;
Tort, ABL ;
Schuh, JF ;
Neto, PF ;
Gomes, MWS ;
Souza, DO ;
Lara, DR .
BEHAVIOURAL PHARMACOLOGY, 2005, 16 (02) :79-84